BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 26037800)

  • 41. Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation.
    Mimura T; Oka S; Koshimoto H; Ueda Y; Watanabe Y; Sugiura T
    Int Arch Allergy Immunol; 2012; 159(2):149-56. PubMed ID: 22652530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination.
    Manterola A; Bernal-Chico A; Cipriani R; Canedo-Antelo M; Moreno-García Á; Martín-Fontecha M; Pérez-Cerdá F; Sánchez-Gómez MV; Ortega-Gutiérrez S; Brown JM; Hsu KL; Cravatt B; Matute C; Mato S
    Biochem Pharmacol; 2018 Nov; 157():189-201. PubMed ID: 30075103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB₁R signaling and anxiety-like behavior.
    Imperatore R; Morello G; Luongo L; Taschler U; Romano R; De Gregorio D; Belardo C; Maione S; Di Marzo V; Cristino L
    J Neurochem; 2015 Nov; 135(4):799-813. PubMed ID: 26223500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cannabinoid receptors in conjunctival epithelium: identification and functional properties.
    Iribarne M; Torbidoni V; Julián K; Prestifilippo JP; Sinha D; Rettori V; Berra A; Suburo AM
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4535-44. PubMed ID: 18566465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.
    Yang Y; Yang H; Wang Z; Varadaraj K; Kumari SS; Mergler S; Okada Y; Saika S; Kingsley PJ; Marnett LJ; Reinach PS
    Cell Signal; 2013 Feb; 25(2):501-11. PubMed ID: 23142606
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocannabinoid System Contributes to Liver Injury and Inflammation by Activation of Bone Marrow-Derived Monocytes/Macrophages in a CB1-Dependent Manner.
    Mai P; Yang L; Tian L; Wang L; Jia S; Zhang Y; Liu X; Yang L; Li L
    J Immunol; 2015 Oct; 195(7):3390-401. PubMed ID: 26320250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and function of endocannabinoid receptors in the human adrenal cortex.
    Ziegler CG; Mohn C; Lamounier-Zepter V; Rettori V; Bornstein SR; Krug AW; Ehrhart-Bornstein M
    Horm Metab Res; 2010 Feb; 42(2):88-92. PubMed ID: 19862666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cannabis, cannabinoid receptors, and endocannabinoid system: yesterday, today, and tomorrow.
    Wu J
    Acta Pharmacol Sin; 2019 Mar; 40(3):297-299. PubMed ID: 30670816
    [No Abstract]   [Full Text] [Related]  

  • 50. Identification and functional characterization of brainstem cannabinoid CB2 receptors.
    Van Sickle MD; Duncan M; Kingsley PJ; Mouihate A; Urbani P; Mackie K; Stella N; Makriyannis A; Piomelli D; Davison JS; Marnett LJ; Di Marzo V; Pittman QJ; Patel KD; Sharkey KA
    Science; 2005 Oct; 310(5746):329-32. PubMed ID: 16224028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of endocannabinoid 1 and 2 (CB1; CB2) receptor agonists on luteal weight, circulating progesterone, luteal mRNA for luteinizing hormone (LH) receptors, and luteal unoccupied and occupied receptors for LH in vivo in ewes.
    Tsutahara NM; Weems YS; Arreguin-Arevalo JA; Nett TM; LaPorte ME; Uchida J; Pang J; McBride T; Randel RD; Weems CW
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):17-24. PubMed ID: 21109016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The endocannabinoid system.
    Kilaru A; Chapman KD
    Essays Biochem; 2020 Sep; 64(3):485-499. PubMed ID: 32648908
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor.
    Bariani MV; Domínguez Rubio AP; Cella M; Burdet J; Franchi AM; Aisemberg J
    Reproduction; 2015 Dec; 150(6):463-72. PubMed ID: 26347521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury.
    Wang PF; Jiang LS; Bu J; Huang XJ; Song W; Du YP; He B
    J Cardiovasc Pharmacol; 2012 Apr; 59(4):301-7. PubMed ID: 22113346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
    Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
    Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycerophosphodiesterase 3 (GDE3) is a lysophosphatidylinositol-specific ectophospholipase C acting as an endocannabinoid signaling switch.
    Briand-Mésange F; Pons V; Allart S; Masquelier J; Chicanne G; Beton N; Payrastre B; Muccioli GG; Ausseil J; Davignon JL; Salles JP; Chap H
    J Biol Chem; 2020 Nov; 295(46):15767-15781. PubMed ID: 32917725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration.
    Pisanti S; Picardi P; Pallottini V; Martini C; Petrosino S; Proto MC; Vitale M; Laezza C; Gazzerro P; Di Marzo V; Bifulco M
    J Cell Physiol; 2015 Dec; 230(12):2905-14. PubMed ID: 25684344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
    Kim J; Watkins BA
    J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
    Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
    Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The inhibitory action of exo- and endocannabinoids on [³H]GABA release are mediated by both CB₁and CB₂receptors in the mouse hippocampus.
    Andó RD; Bíró J; Csölle C; Ledent C; Sperlágh B
    Neurochem Int; 2012 Jan; 60(2):145-52. PubMed ID: 22133429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.